Market revenue in 2023 | USD 1.6 million |
Market revenue in 2030 | USD 2.9 million |
Growth rate | 8.7% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Qiagen NV, Abcam PLC, Takara Bio Inc, Revvity Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, HTG Molecular Diagnostics Inc, Meridian Bioscience, New England Biolabs, Norgen Biotek, System Biosciences, Amoy Diagnostics, EntroGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mirna sequencing and assay market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 81.25% in 2023. Horizon Databook has segmented the Saudi Arabia mirna sequencing and assay market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
The growth of the miRNA sequencing market can be attributed to government initiatives such as the launch of awareness programs and rise in funding for research & development. For instance, in 2018, King Abdulaziz City for Science and Technology (KACST) launched the Saudi Genome Program.
This program is intended to reduce and prevent genetic diseases by implementing reliable screening and detection methods as well as creating physical & legislative infrastructure for development of personalized medicine.
In addition, presence of various laboratories and universities, such as United Arab Emirates University (UAEU) and NYU Abu Dhabi, which are prominent buyers of high-end instruments and consumables drives growth. The presence of such prominent end users will help key players expand their businesses in the country, which is anticipated to boost overall miRNA sequencing and assay market in the country.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia mirna sequencing and assay market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia mirna sequencing and assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account